Sage Therapeutics gets acquired by Maryland drugmaker for up to $795 million
Following a turbulent few years, Sage Therapeutics has reached an agreement with Maryland-based Supernus Pharmaceuticals, which will acquire the Cambridge biotech in a deal that could be worth up to $795 million, the companies announced Monday. The deal is …